Variety of qualified individuals: CDEC mentioned the uncertainty in the amount of individuals with reasonably intense to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some sufferers who're classified as having moderate or reasonable illness may have a severe bleeding phenotype, which https://troyxceff.blogofoto.com/66979980/the-definitive-guide-to-hemgenix